Cyclophosphamide (post-transplant)
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for Cyclophosphamide (post-transplant), covering 2018-07-18 to 2026-02-17. Get the full timeline:
Most recent: Clinical Trial Update: Busulfan, Fludarabine Phosphate, and Post-Transplant Cyclophosphamide in Treating Patients With Blood Cancer Undergoing Donor Stem Cell Transplant [Phase 2]